Expertise in
7
conditions

Normand Blais

Montreal, QC, CA 
Expertise in
7
conditions
Montreal, QC, CA 

Overview

Normand Blais practices practicing medicine in Montreal, Canada.

Mr. Blais is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Cystectomy.

He is actively involved in clinical research, co-authoring 141 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Montreal, QC H3T1J4, Canada
Other Locations
Canada
Ottawa, ON, Canada
Kingston, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Study of AB-16B5 Combined With Docetaxel in Previously Treated Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
A Phase II Study of AB-16B5 Combined With Docetaxel in Previously Treated Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
Study Drugs: AB-16B5, Docetaxel
Study Phase: Phase 2
A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
A Phase I/II Study of Pembrolizumab in Combination With Nab-Paclitaxel in Patients With Unresectable Stage III or Stage IV Non-Small Cell Lung Carcinoma
A Phase I/II Study of Pembrolizumab in Combination With Nab-Paclitaxel in Patients With Unresectable Stage III or Stage IV Non-Small Cell Lung Carcinoma
Enrollment Status: Completed
Publish Date: February 16, 2021
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Evaluation Of Enoxaparin Pharmacokinetic For Thromboprophylaxis In Burn Care Patients
Evaluation Of Enoxaparin Pharmacokinetic For Thromboprophylaxis In Burn Care Patients
Enrollment Status: Completed
Publish Date: August 03, 2020
View 3 Less Clinical Trials

141 Total Publications

Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives.
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives.
Journal: Current oncology (Toronto, Ont.)
Published: June 21, 2026

Frequently Asked Questions about Normand Blais

Is Normand Blais a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Normand Blais is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Normand Blais participate in research or clinical trials?

Yes. Normand Blais has published 141 articles and abstracts on conditions like Lung Cancer. You can view a list of Normand Blais's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Blais's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile